Protocol Details Sermorelin is administered as a nightly subcutaneous injection
Unlike full-length hGH, AOD 9604 does not stimulate insulin-like growth factor 1 (IGF-1) production, thereby avoiding potential adverse effects on glucose metabolism
This evaluation ought to account for age, sex, family history, prior medical history, environmental exposures, and other established risk determinants that may increase the likelihood of occult malignancy
Your practitioner will recommend a personalised treatment plan during your consultation
Improves energy levels, mental clarity and mood Effective in reducing cravings and improving post-workout recovery Compounded & made-to-order by a U.S
BPC-157 appears on the WADA Prohibited List under the S0 Non-Approved Substances category